| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |